Association between clinical and microbiological efficacy and pharmacokinetic/pharmacodynamic parameters of dalbavancin for the treatment of infections caused by gram-positive microorganisms. (DAPHNE PROJECT)
OBSERVATIONAL STUDY WITH MEDICINES
Clinical trial information
- Promoter: SEVILLE HEALTH RESEARCH MANAGEMENT FOUNDATION
- Execution start: 07/10/24
- End of execution: 30/06/27
- PI: CARMEN HIDALGO TENORIO
